Sputnik V Could Get Emergency Use Approval in 10 Days: Reports

Other Vaccines Under Consideration

ANI reported, quoting top government sources, that in addition to Covishield and COVAXIN, India could have five more vaccines by the end of the third quarter of 2021.

“These vaccines are Sputnik V vaccine (in collaboration with Dr. Reddy’s), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila’s vaccine, and Bharat Biotech’s Intranasal Vaccine,” the source said.

Sources also added that India is encouraging all COVID-19 vaccine manufacturers to come to India so that Indians have “equitable access to the highest quality vaccines in the world”. The government will provide “manufacturing assistance, financial support, and partnership in running and designing clinical trials,” sources told ANI.

India is in the middle of a severe second wave of COVID-19, with fresh cases far outstripping those in the peak of the first wave. On Sunday, the country reported a single-day spike…

Exit mobile version